◆英語タイトル:Qu Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10667
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Qu Biologics Inc (Qu Biologics) is a developer of immunotherapies designed to restore normal immune function. The company develops site specific immunomodulators that restore the body’s innate immune system to treat immune-related diseases and cancer. Its site specific immunotherapy technology restores normal immune function in the targeted tissue to reverse chronic inflammation in diseases including cancer, inflammatory bowel disease and other immune-related conditions. Qu Biologics’ products are used in the treatment of inflammatory bowel disease, lung cancer, ovarian cancer, bone cancer, prostate cancer, ulcerative colitis, rheumatoid arthritis, and ulcerative colitis, among others. The company also offers preclinical research, retrospective studies, compassionate use program, and clinical trials program. It collaborates with other pharmaceutical companies and academic institutions. Qu Biologics is headquartered in Vancouver, British Columbia, Canada.
Qu Biologics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Qu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Qu Biologics Raises USD4.6 Million in Venture Financing 10
Qu Biologics Raises USD1.1 Million in Venture Financing 11
Qu Biologics Raises USD1.7 Million in Venture Financing 12
Partnerships 13
Qu Biologics Enters into Research Agreement with University of British Columbia 13
Qu Biologics Enters into Research Agreement with University of Rochester 14
Equity Offering 15
Qu Biologics Raises USD3 Million in Equity Financing 15
Qu Biologics Raises USD2.5 Million in Private Placement 16
Qu Biologics Inc – Key Competitors 17
Qu Biologics Inc – Key Employees 18
Qu Biologics Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
May 15, 2018: Leading-edge Scientists in Innate Immunity Join Qu Biologics’ Scientific Advisory Board 20
Nov 08, 2017: Qu Biologics recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to Leadership Team 21
Government and Public Interest 22
Apr 04, 2017: Innovation Grant Awarded for Qu Biologics Project with University of Ottawa Scientist 22
Product News 23
Nov 28, 2017: Discovery of Innate Immune Mechanisms of a Novel Microbial-based Approach for the Treatment of Lung Cancer 23
05/23/2017: Qu Biologics Publishes Proof-of-Principle Data for Promising New Treatment for Chronic Obstructive Pulmonary Disease 24
05/03/2017: Qu Biologics invited to present Research Data at International Scientific Meetings 25
04/19/2017: High Response and Remission Rates in Anti-TNFa Naïve Patients Treated with Qu Biologics’ Novel Immune Therapy for Crohn’s Disease 26
03/22/2017: Qu Biologics Discovers That Immune Biomarkers May Predict Response to Novel Immune Therapy for Crohns Disease 27
Clinical Trials 28
Mar 03, 2017: Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
Qu Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Qu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Qu Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Qu Biologics Raises USD4.6 Million in Venture Financing 10
Qu Biologics Raises USD1.1 Million in Venture Financing 11
Qu Biologics Raises USD1.7 Million in Venture Financing 12
Qu Biologics Enters into Research Agreement with University of British Columbia 13
Qu Biologics Enters into Research Agreement with University of Rochester 14
Qu Biologics Raises USD3 Million in Equity Financing 15
Qu Biologics Raises USD2.5 Million in Private Placement 16
Qu Biologics Inc, Key Competitors 17
Qu Biologics Inc, Key Employees 18
List of Figures
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8